Position in QGEN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$435,474
+$56,783 QoQ
Shares Held
10,876
+29.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $212,934,391 across 21 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
289,624 | $55,167,577 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
108,038 | $54,165,930 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
145,137 | $28,043,370 | |
| 4 | NTRA |
Natera, Inc.
|
79,524 | $21,586,789 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
13,894 | $7,314,356 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
13,742 | $7,277,624 | |
| 7 | LH |
Labcorp Holdings Inc.
|
25,164 | $7,045,920 | |
| 8 | ILMN |
Illumina, Inc.
|
37,193 | $6,539,644 |
All Filings in QGEN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $435,474 | 10,876 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $378,691 | 8,421 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $361,461 | 8,090 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $296,530 | 6,170 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $230,099 | 5,731 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $250,080 | 5,616 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $259,110 | 5,686 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $444,141 | 10,809 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $561,019 | 13,050 | Shares | Defined | 2024-05-13 | |
| 2020-03-31 | $1,034,891 | 24,106 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||